Compare Mutual Funds

Pros
3Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

5Y returns in the top 25% of the category.

5Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

Among most bought funds within the category.

Among most bought funds within the category.

Cons

-

-

INDMoney rank
6/8
3/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

13 Years 8 Months

8 Years 1 Months

Fund AUM

₹1217 Cr

₹6454 Cr

Min Investment
  1. SIP ₹500
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

1.21%

0.87%

Exit Load

1%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

44

40

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(8.87%)
  2. Divi's Laboratories Ltd(4.87%)
  3. Ajanta Pharma Ltd(4.7%)
  4. Gland Pharma Ltd(3.98%)
  5. Lupin Ltd(3.8%)
  1. Sun Pharmaceuticals Industries Ltd(12.09%)
  2. Dr Reddy's Laboratories Ltd(7.7%)
  3. Cipla Ltd(7.45%)
  4. Mankind Pharma Ltd(7.03%)
  5. Divi's Laboratories Ltd(6.06%)
No of Sectors

1

2

Top 3 Sectors

Health

(100%)

  1. Health(98.81%)
  2. Basic Materials(1.19%)
Equity %

94.45%

99.82%

Debt %

-

-

P/E

38.11

36.3

P/B

5.35

4.18

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

8.37%

6.6%

3-Month Return

22.25%

19.35%

6-Month Return

15.38%

9.49%

1-Year Return

15.33%

10.51%

3-Year Return

27.52%

27.29%

5-Year Return

15.61%

16.98%

Sharpe

1.16

1.14

Alpha

2.15

2.11

Beta

0.96

0.96

Standard Deviation

16.35

16.45

Information Ratio

0.57

0.42

Description

UTI Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Kamal Gada

Dharmesh Kakkad, Sharmila D’mello

Most Popular Comparisons